Fig. 4
From: Management of iron deficiency anemia in hemodialysis patients based on mean corpuscular volume
Weekly ESA dosage and average ESA dosage in relation to MCV values. a–c Fifty HD patients were divided into 3 groups (MCV ≤ 85 fL, 85 fL < MCV ≤ 90 fL, MCV > 90 fL) according to the MCV values obtained right prior to the Fe-IV therapy. Changes in the weekly ESA dosage required in a 16-week period before and after the Fe-IV therapy. (d-f) Average of the ESA dosage in a 16-week period before (Pre) or after (Post) the Fe-IV therapy. * P < 0.05 vs Pre. n.s., not significant between groups